Spravato, Ketamine Therapy and Addiction Risk

Ketamine-based treatments have become one of the most talked-about developments in mental health care.

People living with severe or treatment-resistant depression may hear about Spravato, ketamine infusions, ketamine-assisted therapy, compounded ketamine lozenges, or online services offering ketamine products for use at home.

Ketamine has also been studied for certain chronic pain conditions.

For someone who has spent months or years struggling with depression or pain, the idea of a treatment that may work relatively quickly can sound promising.

But there is an important distinction that often gets lost online:

Spravato, medically administered ketamine, compounded ketamine products, and recreational ketamine are not the same thing.

That difference becomes especially important for people with a current or previous substance use disorder.

At Serenity Ranch Recovery in Kentucky, we work with people whose addiction, depression, anxiety, trauma, PTSD, and other mental health concerns often overlap. Understanding the benefits and limitations of psychoactive treatments can help individuals and families make more informed decisions about care.

What Is Ketamine?

Ketamine is a dissociative anesthetic that has been used medically for decades.

It affects several systems in the brain, including glutamate activity involving NMDA receptors. These effects can influence pain perception, mood, awareness, memory, and how connected a person feels to their body and surroundings.

Ketamine is FDA-approved as an anesthetic.

Ketamine itself is not FDA-approved specifically for treating psychiatric disorders, although healthcare professionals may prescribe or administer ketamine off-label when they determine that doing so is medically appropriate.

This distinction matters.

A person may receive legitimate ketamine treatment for depression without that particular use being FDA-approved.

That does not mean the treatment is automatically unsafe.

It does mean patients should understand exactly what medication they are receiving, why it is being recommended, how it will be monitored, and what evidence supports the particular treatment plan.

What Is Spravato?

Spravato is the brand name for esketamine nasal spray.

Esketamine is chemically related to ketamine, but Spravato is not simply ordinary ketamine placed into a nasal spray.

Spravato has specific FDA-approved indications involving depression in adults.

Current FDA labeling includes treatment-resistant depression in adults, either by itself or together with an oral antidepressant, as well as depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior when used with an oral antidepressant.

Spravato is administered through a restricted Risk Evaluation and Mitigation Strategy, commonly called a REMS.

Patients receive the medication in an approved healthcare setting and remain under observation afterward.

That monitoring is required because esketamine can produce significant psychoactive and physical effects.

Why Does Spravato Require Supervision?

Spravato carries important warnings involving:

• sedation,

• dissociation,

• respiratory depression,

• abuse and misuse,

• increased blood pressure, and

• certain antidepressant-related suicidal-thought risks.

These warnings do not mean that Spravato is an inappropriate treatment.

They mean that FDA recognizes both a legitimate medical role and risks significant enough to require safeguards.

A person receiving appropriately supervised Spravato should therefore not be treated as though they are engaging in recreational drug use.

At the same time, the existence of a medical indication does not eliminate the importance of considering abuse potential, especially when someone has a history of addiction.

Spravato vs. Ketamine Therapy: What Is the Difference?

The phrase “ketamine therapy” can describe several very different treatments.

Spravato

Spravato contains esketamine and has specific FDA-approved depression indications.

It is administered intranasally in certified healthcare settings and requires monitoring.

Ketamine Infusions

Ketamine may be administered intravenously or through other routes in a clinical setting.

When ketamine itself is used for depression, that use is generally off-label.

Compounded Ketamine

Compounding pharmacies may prepare ketamine in forms such as troches, lozenges, or nasal products.

Compounded medications do not undergo the same FDA premarket review for safety, effectiveness, and quality as FDA-approved medications.

Recreational Ketamine

Recreational ketamine refers to nonmedical use intended to create intoxication or dissociation.

This form of use may involve unknown doses, frequent redosing, polysubstance use, and substantially less medical oversight.

Those four situations should not be treated as interchangeable.

Why Ketamine Treatment Is Receiving So Much Attention

The interest in ketamine is not difficult to understand.

Traditional antidepressants can take time to produce meaningful improvement.

Some people also continue experiencing significant depression after trying multiple treatments.

Spravato provides another option for appropriately selected adults with treatment-resistant depression.

Ketamine and esketamine have therefore generated substantial interest because of their potential to affect depressive symptoms more rapidly than many conventional antidepressants.

But rapid symptom relief is not necessarily the same as long-term recovery.

Depression often involves a combination of biological, psychological, behavioral, interpersonal, and environmental factors.

Medication may improve one part of the problem without resolving everything that contributes to depression.

That is why comprehensive mental health care remains important.

Serenity Ranch Recovery provides structured depression treatment in Kentucky using evidence-based therapies such as cognitive behavioral therapy, dialectical behavior therapy, acceptance and commitment approaches, and trauma-informed care.

Ketamine and Chronic Pain

Ketamine has also been used or investigated for certain chronic pain conditions.

The drug’s effect on NMDA receptors may influence how the nervous system processes pain.

For some patients and certain conditions, clinicians may consider ketamine as part of a broader treatment plan.

However, chronic pain is rarely a simple problem with a single cause.

Pain can interact with:

• sleep disruption,

• depression,

• anxiety,

• trauma,

• physical conditioning,

• previous injuries,

• inflammation,

• stress,

• medication use, and

• substance use.

Temporary improvement in pain intensity does not necessarily mean someone’s mobility, function, emotional health, or overall quality of life improves over the long term.

For many people, chronic pain treatment works best when it includes several approaches.

Is Ketamine Addictive?

Ketamine has recognized abuse and dependence potential.

That statement needs context.

It does not mean everyone receiving supervised Spravato or ketamine therapy will develop an addiction.

Risk becomes more concerning when use begins changing.

Someone may begin:

using ketamine more often than intended,

seeking larger doses,

obtaining ketamine outside medical care,

thinking frequently about the next dose,

using primarily for the dissociative experience,

hiding their use,

or continuing to use despite physical, psychological, financial, or relationship consequences.

These patterns are different from appropriately monitored medical treatment.

Why Dissociation Can Become Appealing

Ketamine’s dissociative effects deserve particular attention in people living with trauma, depression, anxiety, or addiction.

Dissociation can create a temporary sense of distance from painful thoughts, memories, emotions, or physical sensations.

For someone overwhelmed by emotional pain, that feeling may be experienced as relief.

But there is an important difference between treating depression and repeatedly trying to escape how someone feels.

A pattern can develop:

Emotional pain becomes intense.

Ketamine creates temporary distance from that pain.

The drug wears off.

The underlying distress remains.

The person begins wanting the dissociative experience again.

Over time, the person may become more focused on recreating that feeling than on the original therapeutic goal.

For people with a history of addiction, this possibility is worth discussing openly with healthcare providers.

When Depression and Substance Use Occur Together

Depression and addiction frequently reinforce one another.

A person may begin drinking or using drugs to cope with depression.

Substance use may initially seem to provide relief.

Over time, however, it can worsen sleep, relationships, motivation, physical health, mood stability, and everyday functioning.

The worsening depression can then contribute to continued substance use.

This cycle is one reason integrated treatment matters.

Serenity Ranch Recovery provides dual diagnosis treatment in Kentucky for people experiencing both substance use disorders and mental health conditions.

Instead of asking only, “How do we stop the drug?”

Treatment can also ask:

What emotional or psychiatric problem is driving the need to escape?

Ketamine and Trauma

Trauma can complicate the conversation even further.

Some people living with PTSD or unresolved trauma experience intrusive memories, hypervigilance, anxiety, emotional numbness, or persistent distress.

A dissociative drug may feel appealing precisely because it temporarily changes that experience.

But repeatedly disconnecting from painful memories is not the same as processing them.

Evidence-based trauma treatment helps people develop safer ways of responding to traumatic memories, emotional triggers, and nervous-system activation.

Serenity Ranch Recovery’s trauma therapy program in Kentucky may incorporate approaches such as cognitive behavioral therapy, DBT, EMDR, and trauma-informed care.

These therapies are designed to help people work through trauma rather than becoming dependent on intoxication or dissociation to avoid it.

What Is a K-Hole?

“K-hole” is an informal term describing a profound dissociative state associated with ketamine.

Someone experiencing a K-hole may feel completely disconnected from their body or surroundings.

Possible experiences can include:

distorted perceptions of time and space,

hallucinations,

confusion,

difficulty moving or communicating,

memory impairment,

and a frightening sense of being separated from reality.

The term is sometimes used casually in popular culture.

Severe dissociation should not be confused with the controlled effects expected during legitimate medical care.

What Are the Physical Risks of Ketamine?

Ketamine’s risks depend on factors such as dose, frequency, route of administration, other health conditions, medical supervision, and whether other substances are being used.

Potential effects include dizziness, sedation, nausea, vomiting, impaired coordination, increased blood pressure, cognitive impairment, dissociation, and confusion.

Repeated heavy use can create additional problems.

One of the most concerning involves the urinary system.

Ketamine Bladder Syndrome

Chronic heavy ketamine use has been associated with ketamine-induced cystitis, sometimes called ketamine bladder syndrome.

This condition can cause significant inflammation and damage within the urinary tract.

Symptoms may include:

frequent urination,

urgent need to urinate,

painful urination,

pelvic or bladder pain,

blood in the urine,

and reduced bladder capacity.

Severe cases may involve more extensive urinary complications.

Someone experiencing these symptoms while frequently using ketamine should receive medical evaluation.

Real-World Example: Ketamine-Induced Cystitis

Published medical literature contains cases demonstrating how serious ketamine-related urinary damage can become.

One case involved a 46-year-old man who reported daily recreational ketamine use for approximately seven months.

He presented to an emergency department with lower abdominal pain and blood in his urine.

Medical evaluation identified substantial urinary abnormalities, including a thickened bladder wall.

He ultimately required urological treatment and was diagnosed with ketamine-induced cystitis.

Cases like this help distinguish hypothetical warnings from documented physical harm associated with chronic recreational use.

What Are K-Cramps?

“K-cramps” is an informal term describing severe abdominal discomfort reported by some people with chronic ketamine use.

Abdominal pain can have many causes, so someone should never assume ketamine is responsible without appropriate medical evaluation.

However, published medical cases have documented severe abdominal and back pain in people with substantial histories of nonmedical ketamine use.

Persistent or severe abdominal pain requires medical attention.

Can Ketamine Cause Tolerance?

Tolerance refers to changes in how the body responds to repeated exposure to a drug.

Someone using ketamine repeatedly may find that the effects become less intense or that they seek larger or more frequent amounts to achieve the experience they want.

Tolerance by itself is not the same as addiction.

But increasing doses and escalating frequency are important warning signs.

The most useful question is often not whether someone meets a single definition of dependence.

It is whether use is becoming increasingly difficult to control or is causing harm.

What Happens When Someone Stops Heavy Ketamine Use?

There is not one clearly established withdrawal syndrome that occurs in every person who stops ketamine.

Some people with heavy or compulsive ketamine use report:

cravings,

low mood,

anxiety,

irritability,

sleep disruption,

restlessness,

and other psychological symptoms.

Researchers continue studying ketamine use disorder and the most effective approaches for helping people stop.

Another challenge is distinguishing withdrawal-related symptoms from the return of an underlying condition.

Someone who originally began using ketamine because of depression, trauma, or pain may experience those symptoms again after stopping.

This is why comprehensive assessment matters.

Is At-Home Ketamine the Same as Spravato?

No.

Spravato is administered within a specific FDA-required healthcare framework.

Patients receive it in a certified medical setting and remain under observation afterward.

The phrase “at-home ketamine therapy” may refer to compounded ketamine or other treatment arrangements.

The level of medical screening, prescribing, monitoring, pharmacy oversight, and emergency planning can vary considerably.

Consumers should understand exactly what product is being prescribed and who is responsible for monitoring treatment.

Alternatives to Ketamine for Depression

Ketamine-derived treatments are not the only options for depression.

Depending on the individual, treatment may include:

Cognitive Behavioral Therapy

CBT helps people recognize patterns connecting thoughts, emotions, and behavior.

Someone experiencing depression may develop deeply negative beliefs about themselves, their future, or their circumstances.

CBT helps identify and challenge those patterns while developing healthier ways of responding.

Dialectical Behavior Therapy

DBT focuses heavily on emotional regulation, distress tolerance, mindfulness, and interpersonal effectiveness.

These skills may be particularly valuable for people who struggle with intense emotions or use substances to cope.

Acceptance and Commitment Therapy

ACT encourages people to develop a healthier relationship with uncomfortable thoughts and feelings while continuing to engage in actions aligned with personal values.

Trauma-Informed Therapy

When depression is connected to trauma, treatment may need to address traumatic experiences rather than focusing exclusively on depressive symptoms.

Individual Therapy

One-on-one therapy allows people to explore grief, trauma, relationship difficulties, self-esteem, substance-use triggers, and other factors contributing to depression.

Serenity Ranch Recovery incorporates evidence-based and individualized therapies into its mental health treatment programs in Kentucky.

Alternatives to Ketamine for Chronic Pain

Treatment depends heavily on the cause of pain.

For some conditions, clinicians may consider combinations of:

physical therapy,

therapeutic exercise,

cognitive behavioral therapy for pain,

mindfulness-based stress reduction,

sleep interventions,

nonopioid medications,

rehabilitation,

and multidisciplinary medical care.

The goal is not simply to avoid ketamine.

The goal is to find treatment that improves function and quality of life while balancing potential benefits and risks.

This becomes particularly important when someone has a history of opioid, alcohol, benzodiazepine, or other substance misuse.

Questions to Ask Before Beginning Ketamine-Based Treatment

Someone considering ketamine or esketamine treatment may want to ask:

What Medication Am I Actually Receiving?

Determine whether the treatment involves FDA-approved Spravato, off-label ketamine, or a compounded ketamine product.

Is This Use FDA-Approved or Off-Label?

Both can occur legitimately, but patients should know which situation applies.

Who Is Monitoring Me?

Ask who conducts the psychiatric and medical evaluation, monitors side effects, handles emergencies, and decides when treatment should continue or stop.

What Happens If I Begin Wanting More?

Someone with a substance-use history should know what monitoring exists for cravings, dose escalation, or compulsive behavior.

What Is the Long-Term Plan?

Ask whether psychotherapy, behavioral treatment, psychiatric care, physical rehabilitation, and other interventions are part of the treatment strategy.

How Does My Addiction History Affect This Decision?

A substance-use history should be discussed openly rather than treated as irrelevant.

Signs Ketamine Use May Be Becoming a Problem

Warning signs can include:

using more ketamine than intended,

increasing the frequency of use,

obtaining ketamine outside legitimate medical care,

becoming increasingly focused on dissociation,

hiding use,

developing cravings,

continuing despite urinary or abdominal problems,

experiencing work or relationship consequences,

using ketamine with other drugs,

or feeling unable to manage emotions without it.

Someone does not need to reach a severe crisis before seeking an assessment.

Spravato Treatment Is Not the Same as Ketamine Addiction

It is important not to stigmatize people receiving legitimate mental health treatment.

Spravato has an FDA-approved role for specific depressive conditions.

For appropriately selected patients, esketamine may provide meaningful benefit.

The fact that a medication can be misused does not mean every patient taking it is misusing it.

At the same time, medications with psychoactive and reinforcing effects deserve careful monitoring.

Both ideas can be true at once.

A medication can have legitimate therapeutic value while still requiring significant safeguards.

When Residential Treatment May Help

For someone whose depression, trauma, addiction, or substance misuse has become difficult to manage in everyday life, a structured residential environment may provide a different level of support.

Serenity Ranch Recovery provides residential addiction and mental health treatment in Kentucky within a structured setting in Mammoth Cave.

Residential treatment can give people space away from the triggers and routines associated with substance use while providing clinical structure, nursing support, individual therapy, group work, mental health care, and recovery planning.

This approach can be particularly valuable when someone’s depression or trauma repeatedly contributes to substance use.

Dual Diagnosis Treatment at Serenity Ranch Recovery

When depression, anxiety, PTSD, bipolar symptoms, trauma, or another mental health condition occurs alongside addiction, treating only the substance may leave an important part of the problem unresolved.

Serenity Ranch Recovery’s dual diagnosis program addresses both conditions together.

Treatment may include evidence-based psychotherapy, medication management when appropriate, trauma-informed care, individual and family therapy, holistic services, and recovery-focused life skills.

The goal is not merely to stop a substance.

It is to help the person understand why substance use became a coping strategy and develop healthier ways to manage distress.

Frequently Asked Questions About Spravato and Ketamine

Is Spravato the same as ketamine?

No. Spravato contains esketamine, a chemical relative of ketamine. It has specific FDA-approved depression indications and is administered within a restricted medical program.

Is ketamine FDA-approved for depression?

Ketamine itself is FDA-approved as an anesthetic rather than specifically for psychiatric disorders. Healthcare professionals may use ketamine off-label in certain circumstances.

Is Spravato FDA-approved for depression?

Yes. Spravato has FDA-approved indications involving treatment-resistant depression and certain depressive symptoms associated with major depressive disorder.

Can Spravato be addictive?

Spravato carries warnings involving abuse and misuse. That does not mean everyone receiving treatment develops an addiction. Appropriate screening and monitoring remain important.

Can ketamine therapy lead to addiction?

Ketamine has abuse potential. Risk becomes more concerning when use escalates, occurs outside medical supervision, becomes focused on intoxication or dissociation, or continues despite harmful consequences.

What is a K-hole?

A K-hole is an informal term for an intense ketamine-related dissociative state that may involve profound detachment, confusion, hallucinations, impaired movement, and altered perception.

Can ketamine damage the bladder?

Yes. Chronic heavy ketamine use has been associated with ketamine-induced cystitis and other urinary complications.

What are K-cramps?

K-cramps is an informal term used for severe abdominal pain reported by some people with chronic ketamine use. Severe or persistent abdominal pain should receive medical evaluation.

Does ketamine cause withdrawal?

There is not one universally defined ketamine withdrawal pattern. Some people with heavy or compulsive use report cravings, low mood, anxiety, irritability, and sleep problems after stopping.

Is at-home ketamine the same as Spravato?

No. Spravato is administered in certified healthcare settings under its FDA-required REMS program rather than being intended for unsupervised at-home administration.

What therapies can treat depression without ketamine?

Options may include CBT, DBT, acceptance and commitment therapy, individual therapy, trauma-informed therapy, psychiatric medication management, and other evidence-based approaches.

Should someone with a history of addiction receive Spravato?

That decision should be individualized by qualified healthcare professionals. A substance-use history does not automatically determine whether treatment is appropriate, but abuse and misuse risk should be considered carefully.

Where can someone get help if ketamine use becomes difficult to control?

People who are struggling to stop ketamine or another substance can seek an addiction assessment. When depression, anxiety, trauma, or another mental health condition is also present, dual diagnosis care may be especially important.

Finding Mental Health and Addiction Treatment in Kentucky

Ketamine-based therapies illustrate an important principle in modern behavioral health care.

A treatment does not need to be either completely good or completely dangerous.

The real question is whether it is appropriate for a particular person, whether the benefits outweigh the risks, and whether appropriate monitoring is in place.

For people living with both addiction and mental health concerns, treatment often needs to go further than managing one symptom.

Serenity Ranch Recovery in Mammoth Cave, Kentucky provides residential treatment for substance use disorders, depression, trauma, anxiety, PTSD, and co-occurring behavioral health conditions.

If ketamine, alcohol, opioids, prescription medications, or another substance has become difficult to control, or if depression and substance use have begun reinforcing one another, our admissions team can help you understand your options.

Call 270-515-5618 to speak confidentially with Serenity Ranch Recovery.

Clinical Sources and References

U.S. Food and Drug Administration. Spravato prescribing information and Risk Evaluation and Mitigation Strategy requirements.

U.S. Food and Drug Administration. June 2026 warning letters involving online sellers marketing unapproved ketamine products for psychiatric conditions.

U.S. Food and Drug Administration. FDA information regarding compounded ketamine products used for psychiatric disorders.

Peer-reviewed medical literature. Research examining esketamine for treatment-resistant depression, ketamine-induced cystitis, chronic recreational ketamine use, and ketamine use disorder.

Medical Disclaimer: This article is for educational purposes and does not diagnose a medical condition, recommend stopping a prescribed medication, or replace individualized medical advice. Do not discontinue Spravato, ketamine, antidepressants, pain medication, or another prescribed treatment without speaking with the healthcare professional managing your care.